{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:47:06Z","timestamp":1794952026679,"version":"4.9.1"},"reference-count":21,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,3,31]],"date-time":"2007-03-31T00:00:00Z","timestamp":1175299200000},"content-version":"vor","delay-in-days":5294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1992,10]]},"abstract":"<jats:sec><jats:title>SUMMARY<\/jats:title><jats:p>Four hundred and sixty\u2010four patients with duodenal ulcer disease received continuous maintenance treatment with ranitidine for up to 9 years. Treatment failure was defined as either the first symptomatic recurrence of ulcer or the first ulcer recurrence accompanied by haemorrhage. Life tables were constructed using the Kaplan\u2010Meier product\u2010limit method; comparisons of survival curves were performed using the log\u2010rank test; and multivariate analysis was carried out using the Cox proportional hazards model.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>. The proportion of patients remaining free from symptomatic recurrence of ulcer during maintenance treatment with either 150 mg\/day or 300 mg\/day ranitidine was: 95% at 1 year; 88% at 3 years; 86% at 5 years; and 81% at 7 and 9 years (95% C.I. 76\u201386%). Young age and the absence of exposure to non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) at the time of diagnosis of ulcer were shown to increase the likelihood of developing ulcer recurrence. The rate of ulcer recurrence after 9 years of maintenance treatment (17%) was significantly less than that after 5 years without active anti\u2010ulcer therapy (80%),<jats:italic>P<\/jats:italic>= 0.0001.<\/jats:p><jats:p>The proportion of patients who remained free from ulcer haemorrhage during maintenance treatment was: 99.1% at 1 year and 98.1 % at 5 and 9 years (95 % C.I. 96.7\u201399.6%). The risk of haemorrhage was significantly greater in patients who were not receiving active treatment (12.4% at 5 years) than in patients receiving maintenance treatment (&lt; 2% at 9 years),<jats:italic>P<\/jats:italic>= 0.0001 (log\u2010rank test). Patients who had originally presented with haemorrhage had an increased risk of further ulcer bleeding compared with patients who presented with pain (<jats:italic>P<\/jats:italic>= 0.0013). A significantly greater proportion of patients with NSAID\u2010associated duodenal ulcers remained free from ulcer recurrence during maintenance treatment compared with patients suffering from\u2018idiopathic\u2019 ulcers (<jats:italic>P<\/jats:italic>= 0.0238), although there was no difference between the two groups in respect of haemorrhage during maintenance treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Concltisions<\/jats:title><jats:p>(a) Continuous maintenance treatment with ranitidine for up to nine years successfully prevents ulcer recurrence in more than 80% of patients with duodenal ulcer disease.<\/jats:p><jats:p>(b) Young age increases the risk of ulcer recurrence during maintenance treatment with ranitidine. Ulcers associated with NSAID\u2010intake at the time of diagnosis have a lesser risk of recurrence during maintenance treatment.<\/jats:p><jats:p>(c) The risk of haemorrhage in patients with ulcer disease receiving maintenance treatment with ranitidine for nine years was &lt; 2% compared with &gt; 12% in untreated patients observed for 5 years.<\/jats:p><jats:p>(d) Patients whose ulcer disease presents with haemorrhage have a greater risk of further bleeding than patients who present with pain.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.1992.tb00577.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T11:59:45Z","timestamp":1279886385000},"page":"629-645","source":"Crossref","is-referenced-by-count":32,"title":["Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease"],"prefix":"10.1111","volume":"6","author":[{"given":"J. G.","family":"PENSTON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. G.","family":"WORMSLEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,3,31]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528708991481"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1988.tb00713.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909089269"},{"key":"e_1_2_1_5_2","article-title":"Long term therapy of peptic ulcer: our experience with ranitidine after 4 years","volume":"69","author":"Susi D","year":"1987","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1990.tb00481.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6120.1095"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/00365521.1984.12005741","article-title":"Safety of ranitidine maintenance treatment of duodenal ulcer","volume":"19","author":"Boyd E J S","year":"1984","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529009094493"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"24","author":"Cox D R","year":"1972","journal-title":"J R Stat Soc"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529009094496"},{"issue":"1","key":"e_1_2_1_14_2","first-page":"40","article-title":"Intermittent treatment of duodenal ulcer for long term medical management","volume":"64","author":"Bardhan K D","year":"1988","journal-title":"Postgrad Med J"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198801000-00001"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529009094495"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.2.151"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00541.x"},{"key":"e_1_2_1_19_2","first-page":"A239","article-title":"Long\u2010term recurrence rates of peptic ulceration and re\u2010bleeding with H2 maintenance, surgery or no maintenance therapy","volume":"96","author":"Jensen D M","year":"1989","journal-title":"Gastroenterology"},{"key":"e_1_2_1_20_2","first-page":"A65","article-title":"Randomized controlled study of ranitidine maintenance for patients with a recent severe duodenal ulcer haemorrhage","volume":"98","author":"Jensen D M","year":"1990","journal-title":"Gastroenterology"},{"key":"e_1_2_1_21_2","first-page":"A150","article-title":"Two\u2010year maintenance treatment of duodenal ulcer with ranitidine","volume":"100","author":"Ruszniewski P","year":"1991","journal-title":"Gastroenterology"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1989.tb00241.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.1992.tb00577.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.1992.tb00577.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T08:35:19Z","timestamp":1740299719000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.1992.tb00577.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,10]]}},"alternative-id":["10.1111\/j.1365-2036.1992.tb00577.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.1992.tb00577.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10]]}}}